Evidence map›Paper›PMID 26910425›Full record

ArticleBiophysical journal2016

Binding of NFκB Appears to Twist the Ankyrin Repeat Domain of IκBα.

Morten Beck Trelle, Kristen M Ramsey, Taehyung C Lee, Weihua Zheng, Jorge Lamboy, Peter G Wolynes, Ashok Deniz, Elizabeth A Komives

Abstract read
In one paragraph

Article in Biophysical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Post-translational Modifications of IκBα: The State of the Art.Frontiers in cell and developmental biology · 2020
    Review
  6. Article
  7. Article
  8. Functional importance of stripping in NFκB signaling revealed by a stripping-impaired IκBα mutant.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Morten Beck TrelleDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California.
Kristen M RamseyDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California.
Taehyung C LeeDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California.
Weihua ZhengDepartment of Chemistry, Rice University, Houston, Texas.
Jorge LamboyDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California.
Peter G WolynesDepartment of Chemistry, Rice University, Houston, Texas.
Ashok DenizDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California.
Elizabeth A KomivesDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California. Electronic address: ekomives@ucsd.edu.

Funding

STRUCTURE AND STABILITY OF IKB/NF-KB COMPLEXESP01GM071862 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 2006 to 2016
$14.9M
MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008326 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 1989 to 2020
$7.5M
Synapt G2-S System with HXMS AutomationS10OD016234 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 2013 to 2013
$600k
NIGMS NIH HHS 1P01-GM71862NIGMS NIH HHS P01 GM071862NIGMS NIH HHS T32 GM008326NIH HHS 1S10OD016234-01NIH HHS S10 OD016234
6 · The paper itself

Abstract

Total internal reflection fluorescence-based single-molecule Förster resonance energy transfer (FRET) measurements were previously carried out on the ankyrin repeat domain (ARD) of IκBα, the temporally regulated inhibitor of canonical NFκB signaling. Under native conditions, most of the IκBα molecules showed stable, high FRET signals consistent with distances between the fluorophores estimated from the crystal structures of the NFκB(RelA/p50)-IκBα complex. Similar high FRET efficiencies were found when the IκBα molecules were either free or in complex with NFκB(RelA/p50), and were interpreted as being consistent with the crystallographically observed ARD structure. An exception to this was observed when the donor and acceptor fluorophores were attached in AR3 (residue 166) and AR6 (residue 262). Surprisingly, the FRET efficiency was lower for the bound IκBα molecules (0.67) than for the free IκBα molecules (0.74), apparently indicating that binding of NFκB(RelA/p50) stretches the ARD of IκBα. Here, we conducted confocal-based single-molecule FRET studies to investigate this phenomenon in greater detail. The results not only recapitulated the apparent stretching of the ARD but also showed that the effect was more pronounced when the N-terminal domains (NTDs) of both RelA and p50 were present, even though the interface between NFκB(RelA/p50) and IκBα encompasses only the dimerization domains. We also performed mass spectrometry-detected amide hydrogen/deuterium exchange (HDXMS) experiments on IκBα as well as IκBα bound to dimerization-domain-only constructs or full-length NFκB(RelA/p50). Although we expected the stretched IκBα to have regions with increased exchange, instead the HDXMS experiments showed decreases in exchange in AR3 and AR6 that were more pronounced when the NFκB NTDs were present. Simulations of the interaction recapitulated the increased distance between residues 166 and 262, and also provide a plausible mechanism for a twisting of the IκBα ARD induced by interactions of the IκBα proline-glutamate-serine-threonine-rich sequence with positively charged residues in the RelA NTD.

Indexed as

Ankyrin RepeatMolecular Dynamics SimulationAmidesNF-kappa BNF-KappaB Inhibitor alphaProtein BindingAmidesNF-kappa BNF-KappaB Inhibitor alpha

Identifiers

PMID26910425
PMCPMC4776026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.